Phuong Khanh Morrow Crispr Therapeutics Ag (CRSP) insider trading activity

CRSP Quotes by TradingView

Phuong Khanh Morrow is Chief Medical Officer of CRISPR Therapeutics AG. Currently has a direct ownership of 4,411 shares of CRSP, which is worth approximately $176,528. The most recent transaction as insider was on May 24, 2023, when has been sold 2,527 shares (Common Shares) at a price of $65.91 per share, resulting in proceeds of $166,554. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.41K
0% 3M change
0% 12M change
Total Value Held $176,528

Phuong Khanh Morrow Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 24 2023
SELL
Payment of exercise price or tax liability
$166,554 $65.91 p/Share
2,527 Reduced 36.42%
4,411 Common Shares
May 23 2023
BUY
Exercise of conversion of derivative security
-
6,938 Added 50.0%
6,938 Common Shares
PKM

Phuong Khanh Morrow

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRSP